Cleared Special

K112489 - SWIFT FX BELLA

K112489 is the FDA 510(k) clearance for SWIFT FX BELLA by Resmed, Ltd.. It is a Class 2 Anesthesiology device (product code BZD) cleared through the Special 510(k) pathway after a 100-day FDA review.

K112489 · Resmed, Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2011
Decision
100d
Days
Class 2
Risk

K112489 is an FDA 510(k) clearance for the SWIFT FX BELLA. Classified as Ventilator, Non-continuous (respirator) (product code BZD), Class II - Special Controls.

Submitted by Resmed, Ltd. (Bella Vist Nsw, AU). The FDA issued a Cleared decision on December 7, 2011 after a review of 100 days - within the typical 510(k) review window.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5905 - the FDA anesthesiology and respiratory device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Resmed, Ltd. devices

Submission Details

510(k) Number K112489 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 29, 2011
Decision Date December 07, 2011
Days to Decision 100 days
Submission Type Special
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
40d faster than avg
Panel avg: 140d · This submission: 100d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code BZD Ventilator, Non-continuous (respirator)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5905
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BZD Ventilator, Non-continuous (respirator)

All 246
Devices cleared under the same product code (BZD) and FDA review panel - the closest regulatory comparables to K112489.
SIMPLE T NASAL MASK
K120145 · Respironics, Inc. · Mar 2012
MIRAGE QUATTRO
K113127 · Resmed, Ltd. · Jan 2012
REMSTAR AUTO A-FLEX HT
K113068 · Respironics, Inc. · Dec 2011
TASMAN
K112393 · Resmed, Ltd. · Nov 2011
INFOSEND GSM
K110316 · Fisher &Paykel Healthcare , Ltd. · Aug 2011
TRUBLUE NASAL MASK
K110405 · Respironics, Inc. · Jun 2011